載入...
Alemtuzumab as Treatment for Multiple Sclerosis
Alemtuzumab, the first monoclonal antibody to be used as a therapy and the first to be humanized, was introduced into the treatment of multiple sclerosis in 1991 after its successful use in hematology, oncology, and transplantation medicine. One phase 2 and two phase 3 trials of this lymphocyte-depl...
Na minha lista:
| 發表在: | Cold Spring Harb Perspect Med |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Cold Spring Harbor Laboratory Press
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6169984/ https://ncbi.nlm.nih.gov/pubmed/29500306 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/cshperspect.a032029 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|